Q1 2022: Order pattern in Americas gave a weaker start to the year
Important events during the first quarter · Net sales decreased by 10% (-16% adjusted for currency effects) to SEK 155 m (171). · The EBITDA margin was 25% (28). · The Americas were affected by customers' order patterns, which contributed to a weaker quarter. EMEA and APAC on par with the previous year adjusted for milestone-related revenue. · Important step in the technological transfer of Blis products with the first commercial production batch of BLIS K12. · New laboratory completed in Lund with the aim of improving pre-clinical ability and providing increased